Celltrion Healthcare Co Ltd
KOSDAQ:091990
Celltrion Healthcare Co Ltd
KOSDAQ:091990
Price:
75 900
KRW
-5.6%
Market Closed
Market Cap:
12.5T
KRW
Income Statement
Earnings Waterfall
Celltrion Healthcare Co Ltd
Celltrion Healthcare Co Ltd
|
Revenue
|
2.1T
KRW
|
|
Cost of Revenue
|
-1.4T
KRW
|
|
Gross Profit
|
620.7B
KRW
|
|
Operating Expenses
|
-425.9B
KRW
|
|
Operating Income
|
194.8B
KRW
|
|
Other Expenses
|
-58.9B
KRW
|
|
Net Income
|
136B
KRW
|
Income Statement
Celltrion Healthcare Co Ltd
Celltrion Healthcare Co Ltd
Currency: KRW
Millions
TTM
| Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||
| Revenue |
733 263
N/A
|
738 881
+1%
|
874 221
+18%
|
870 062
0%
|
920 922
+6%
|
942 461
+2%
|
896 788
-5%
|
940 214
+5%
|
713 487
-24%
|
805 635
+13%
|
906 649
+13%
|
976 014
+8%
|
1 100 878
+13%
|
1 237 267
+12%
|
1 372 784
+11%
|
1 554 164
+13%
|
1 627 597
+5%
|
1 626 987
0%
|
1 639 954
+1%
|
1 585 654
-3%
|
1 804 486
+14%
|
1 863 891
+3%
|
1 949 646
+5%
|
2 036 930
+4%
|
1 972 188
-3%
|
2 060 053
+4%
|
2 066 847
+0%
|
|
| Gross Profit | ||||||||||||||||||||||||||||
| Cost of Revenue |
(537 831)
|
(541 090)
|
(632 912)
|
(650 435)
|
(696 793)
|
(753 270)
|
(727 461)
|
(756 710)
|
(644 612)
|
(728 424)
|
(831 817)
|
(896 116)
|
(891 574)
|
(967 395)
|
(1 011 062)
|
(1 067 377)
|
(1 085 822)
|
(1 097 392)
|
(1 111 541)
|
(1 156 565)
|
(1 373 984)
|
(1 411 410)
|
(1 483 396)
|
(1 492 232)
|
(1 410 434)
|
(1 449 393)
|
(1 446 156)
|
|
| Gross Profit |
195 432
N/A
|
197 791
+1%
|
241 309
+22%
|
219 628
-9%
|
224 129
+2%
|
189 191
-16%
|
169 327
-10%
|
183 502
+8%
|
68 876
-62%
|
77 210
+12%
|
74 831
-3%
|
79 898
+7%
|
209 304
+162%
|
269 872
+29%
|
361 722
+34%
|
486 787
+35%
|
541 775
+11%
|
529 595
-2%
|
528 413
0%
|
429 088
-19%
|
430 502
+0%
|
452 482
+5%
|
466 250
+3%
|
544 698
+17%
|
561 754
+3%
|
610 660
+9%
|
620 691
+2%
|
|
| Operating Income | ||||||||||||||||||||||||||||
| Operating Expenses |
(40 130)
|
(44 000)
|
(49 222)
|
(57 296)
|
(70 477)
|
(74 369)
|
(84 848)
|
(90 516)
|
(94 075)
|
(101 474)
|
(105 073)
|
(108 862)
|
(126 511)
|
(140 655)
|
(154 920)
|
(173 613)
|
(179 663)
|
(191 793)
|
(201 289)
|
(207 648)
|
(231 065)
|
(260 019)
|
(275 865)
|
(303 823)
|
(332 867)
|
(375 849)
|
(425 876)
|
|
| Selling, General & Administrative |
(32 822)
|
(37 060)
|
(42 238)
|
(48 877)
|
(58 259)
|
(64 008)
|
(73 622)
|
(78 597)
|
(80 246)
|
(86 805)
|
(89 475)
|
(92 799)
|
(107 768)
|
(118 383)
|
(127 857)
|
(142 668)
|
(146 992)
|
(155 485)
|
(166 219)
|
(173 511)
|
(196 761)
|
(209 741)
|
(231 188)
|
(264 599)
|
(309 809)
|
(352 643)
|
(393 478)
|
|
| Research & Development |
(7 130)
|
(6 785)
|
(6 845)
|
(8 277)
|
(12 036)
|
0
|
(11 019)
|
(11 674)
|
(13 505)
|
(13 953)
|
(14 479)
|
(14 486)
|
(16 684)
|
(20 011)
|
(24 626)
|
(28 353)
|
(29 733)
|
(33 177)
|
(31 618)
|
(29 755)
|
(29 227)
|
(24 427)
|
(18 708)
|
(13 518)
|
(17 750)
|
(17 367)
|
(25 918)
|
|
| Depreciation & Amortization |
(178)
|
(156)
|
(140)
|
(143)
|
(182)
|
0
|
(206)
|
(243)
|
(324)
|
(714)
|
(1 118)
|
(1 577)
|
(2 059)
|
(2 261)
|
(2 437)
|
(2 592)
|
(2 938)
|
(3 131)
|
(3 452)
|
(4 382)
|
(5 077)
|
(5 320)
|
(5 438)
|
(5 175)
|
(5 308)
|
(5 839)
|
(6 480)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
(10 361)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20 531)
|
(20 531)
|
(20 531)
|
0
|
0
|
0
|
|
| Operating Income |
155 302
N/A
|
153 791
-1%
|
192 087
+25%
|
162 331
-15%
|
153 652
-5%
|
114 822
-25%
|
84 479
-26%
|
92 988
+10%
|
(25 200)
N/A
|
(24 263)
+4%
|
(30 241)
-25%
|
(28 964)
+4%
|
82 793
N/A
|
129 217
+56%
|
206 802
+60%
|
313 174
+51%
|
362 112
+16%
|
337 801
-7%
|
327 123
-3%
|
221 439
-32%
|
199 437
-10%
|
192 462
-3%
|
190 385
-1%
|
240 875
+27%
|
228 887
-5%
|
234 811
+3%
|
194 815
-17%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||
| Interest Income Expense |
(18 267)
|
(15 342)
|
50 109
|
40 967
|
15 195
|
132 202
|
84 694
|
74 762
|
49 520
|
(10 825)
|
(23 451)
|
(12 402)
|
(6 966)
|
32 334
|
20 931
|
12 432
|
(47 973)
|
(86 959)
|
(57 147)
|
(19 749)
|
18 634
|
36 631
|
44 450
|
126 637
|
7 887
|
55 777
|
35 023
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(360)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(20 531)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(1)
|
0
|
0
|
0
|
30
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
(3)
|
0
|
3
|
0
|
7
|
0
|
0
|
4
|
2
|
(43)
|
(103)
|
(92)
|
(174)
|
(126)
|
(91)
|
|
| Total Other Income |
1 717
|
(4 734)
|
(9 689)
|
(9 489)
|
37 265
|
3 145
|
1 773
|
447
|
90
|
(14 398)
|
6 232
|
11 218
|
(101)
|
3 388
|
(12 114)
|
(15 767)
|
534
|
669
|
694
|
851
|
714
|
(4 486)
|
(2 784)
|
(2 798)
|
(7 027)
|
(2 156)
|
(4 595)
|
|
| Pre-Tax Income |
138 751
N/A
|
133 714
-4%
|
232 505
+74%
|
193 808
-17%
|
206 136
+6%
|
250 168
+21%
|
170 946
-32%
|
168 197
-2%
|
24 409
-85%
|
(49 485)
N/A
|
(47 459)
+4%
|
(30 147)
+36%
|
75 362
N/A
|
164 939
+119%
|
215 621
+31%
|
309 841
+44%
|
314 680
+2%
|
251 511
-20%
|
270 669
+8%
|
202 545
-25%
|
198 257
-2%
|
224 564
+13%
|
231 947
+3%
|
364 622
+57%
|
229 573
-37%
|
288 306
+26%
|
225 153
-22%
|
|
| Net Income | ||||||||||||||||||||||||||||
| Tax Provision |
(41 585)
|
(43 258)
|
(68 526)
|
(60 786)
|
(48 698)
|
(58 574)
|
(39 300)
|
(39 342)
|
(13 023)
|
6 207
|
1 677
|
(11 876)
|
(10 400)
|
(29 624)
|
(42 358)
|
(60 625)
|
(74 273)
|
(55 789)
|
(57 660)
|
(35 022)
|
(45 690)
|
(59 920)
|
(91 900)
|
(127 555)
|
(82 394)
|
(130 663)
|
(89 202)
|
|
| Income from Continuing Operations |
97 166
|
90 457
|
163 981
|
133 023
|
157 439
|
191 594
|
131 646
|
128 855
|
11 386
|
(43 278)
|
(45 782)
|
(42 023)
|
64 962
|
135 315
|
173 263
|
249 217
|
240 407
|
195 723
|
213 010
|
167 523
|
152 567
|
164 645
|
140 048
|
237 067
|
147 179
|
157 644
|
135 951
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
| Net Income (Common) |
97 166
N/A
|
90 457
-7%
|
163 981
+81%
|
133 023
-19%
|
157 439
+18%
|
191 594
+22%
|
131 646
-31%
|
128 855
-2%
|
11 386
-91%
|
(43 278)
N/A
|
(45 782)
-6%
|
(42 023)
+8%
|
64 962
N/A
|
135 315
+108%
|
173 263
+28%
|
249 217
+44%
|
240 407
-4%
|
195 724
-19%
|
213 011
+9%
|
167 524
-21%
|
152 567
-9%
|
164 644
+8%
|
140 048
-15%
|
237 067
+69%
|
147 178
-38%
|
157 644
+7%
|
135 951
-14%
|
|
| EPS (Diluted) |
771.15
N/A
|
723.65
-6%
|
1 232.93
+70%
|
886.82
-28%
|
1 100.97
+24%
|
1 236.09
+12%
|
849.32
-31%
|
831.32
-2%
|
74.41
-91%
|
-284.72
N/A
|
-297.28
-4%
|
-274.66
+8%
|
444.94
N/A
|
896.12
+101%
|
1 125.08
+26%
|
1 618.29
+44%
|
1 592.09
-2%
|
1 254.64
-21%
|
1 356.99
+8%
|
1 026.34
-24%
|
953.36
-7%
|
1 019.83
+7%
|
868.01
-15%
|
1 468.51
+69%
|
949.23
-35%
|
981.61
+3%
|
846.74
-14%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
